photo
Speaker

Steven Fruchtman, MD

PRESIDENT & CEO, ONCONOVA THERAPEUTICS, INC.
Newtown, Pennsylvania, United States
Dr. Fruchtman joined Onconova in January 2015 as Chief Medical Officer. He was promoted to President in July 2018 and to President & CEO in January 2019. He has extensive experience in large and small biopharmaceutical companies and has led successful clinical development programs while serving in senior positions at Ortho Biotech Products, Novartis, Allos Therapeutics, Spectrum Pharmaceuticals and Syndax Pharmaceuticals.
Dr. Fruchtman received his medical degree from New York Medical College with the distinction of membership in the Alpha Omega Alpha honorary medical fraternity.
Speaking In
[Available On-Demand]
Onconova Therapeutics is a biopharmaceutical company focused on discovering and developing novel…